Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries

Marlieke E A de Kraker

doi:10.1371/journal.pmed.1004262

Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries

PLoS Med. 2023 Jul 12;20(7):e1004262. doi: 10.1371/journal.pmed.1004262. eCollection 2023 Jul.

Author

Marlieke E A de Kraker^{1

2}

Affiliations

¹ Infection Control program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
² WHO collaborating center, Geneva, Switzerland.

Abstract

Marlieke de Kraker discusses a systematic review and meta-analysis reporting the magnitude and consequences of bloodstream infections in low- and middle-income countries.

Copyright: © 2023 Marlieke E. A. de Kraker. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Publication types

Comment

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Developing Countries
Drug Resistance, Bacterial
Humans
Meta-Analysis as Topic
Sepsis* / drug therapy
Systematic Reviews as Topic

Substances

Anti-Bacterial Agents

Grants and funding

MdK received no financial support for the research, authorship, and/or publication of this article.